Home » Authors » Jim Stommen

Articles by Jim Stommen

Reimbursement in forefront as industry, public policy issue

March 18, 2005

Wary of government controls, economist cites value model

March 17, 2005

Facing uncertainties, planning seen as key to product process

March 16, 2005

Common ground seen in idea generation, product portfolio

March 15, 2005

Corporate chiefs offer views on leadership, other topics

March 14, 2005

Execs share lessons learned, with seriousness and laughs

March 11, 2005

Parallel FDA/CMS reviews? Bring them on, says Schultz

March 10, 2005

Panel: Embrace compliance, because 'they're out to get you'

March 10, 2005

Lots of dialogue being heard about device deals, financings

March 9, 2005

Panel: Embrace compliance, because 'they're out to get you'

March 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.